Literature DB >> 16798089

Mapping the global extent of malaria in 2005.

Carlos A Guerra1, Robert W Snow, Simon I Hay.   

Abstract

Guidelines for travellers on malaria chemoprophylaxis, the altitude limits of dominant vector species, climate suitability for malaria transmission and human population density thresholds have been used to map the crude spatial limits of Plasmodium falciparum and Plasmodium vivax transmission on a global scale. These maps suggest that 2.510 and 2.596 billion people were at possible risk of transmission of P. falciparum and P. vivax, respectively, in 2005. Globally, 75 per cent of humans who are exposed to P. falciparum risk live in only ten countries.

Entities:  

Mesh:

Year:  2006        PMID: 16798089      PMCID: PMC3111076          DOI: 10.1016/j.pt.2006.06.006

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  17 in total

1.  Climatic suitability for malaria transmission in Africa, 1911-1995.

Authors:  Jennifer Small; Scott J Goetz; Simon I Hay
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

2.  A global index representing the stability of malaria transmission.

Authors:  Anthony Kiszewski; Andrew Mellinger; Andrew Spielman; Pia Malaney; Sonia Ehrlich Sachs; Jeffrey Sachs
Journal:  Am J Trop Med Hyg       Date:  2004-05       Impact factor: 2.345

Review 3.  Determining global population distribution: methods, applications and data.

Authors:  D L Balk; U Deichmann; G Yetman; F Pozzi; S I Hay; A Nelson
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

Review 4.  Defining the global spatial limits of malaria transmission in 2005.

Authors:  C A Guerra; R W Snow; S I Hay
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

Review 5.  Global environmental data for mapping infectious disease distribution.

Authors:  S I Hay; A J Tatem; A J Graham; S J Goetz; D J Rogers
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

6.  From predicting mosquito habitat to malaria seasons using remotely sensed data: practice, problems and perspectives.

Authors:  S I Hay; R W Snow; D J Rogers
Journal:  Parasitol Today       Date:  1998-08

Review 7.  A climate-based distribution model of malaria transmission in sub-Saharan Africa.

Authors:  M H Craig; R W Snow; D le Sueur
Journal:  Parasitol Today       Date:  1999-03

8.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

Review 9.  The global distribution and population at risk of malaria: past, present, and future.

Authors:  Simon I Hay; Carlos A Guerra; Andrew J Tatem; Abdisalan M Noor; Robert W Snow
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

Review 10.  Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa.

Authors:  Eline L Korenromp; Brian G Williams; Sake J de Vlas; Eleanor Gouws; Charles F Gilks; Peter D Ghys; Bernard L Nahlen
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

View more
  114 in total

1.  Use of Bayesian geostatistical prediction to estimate local variations in Schistosoma haematobium infection in western Africa.

Authors:  Archie C A Clements; Sonja Firth; Robert Dembelé; Amadou Garba; Seydou Touré; Moussa Sacko; Aly Landouré; Elisa Bosqué-Oliva; Adrian G Barnett; Simon Brooker; Alan Fenwick
Journal:  Bull World Health Organ       Date:  2009-07-27       Impact factor: 9.408

2.  Bayesian geostatistics in health cartography: the perspective of malaria.

Authors:  Anand P Patil; Peter W Gething; Frédéric B Piel; Simon I Hay
Journal:  Trends Parasitol       Date:  2011-03-17

3.  Lack of molecular correlates of Plasmodium vivax ookinete development.

Authors:  Viengngeun Bounkeua; Fengwu Li; Raul Chuquiyauri; Shira R Abeles; Colleen M McClean; Victor Neyra; Alejandro Llanos-Cuentas; Pablo P Yori; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

4.  In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China.

Authors:  Feng Lu; Qi Gao; Kesinee Chotivanich; Hui Xia; Jun Cao; Rachanee Udomsangpetch; Liwang Cui; Jetsumon Sattabongkot
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

Review 5.  In silico studies on DARC.

Authors:  Alexandre G de Brevern; Ludovic Autin; Yves Colin; Olivier Bertrand; Catherine Etchebest
Journal:  Infect Disord Drug Targets       Date:  2009-06

6.  Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.

Authors:  Céline Barnadas; Arsène Ratsimbasoa; Magali Tichit; Christiane Bouchier; Martial Jahevitra; Stéphane Picot; Didier Ménard
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

7.  Plasmodium vivax vaccine research: insights from Colombian studies.

Authors:  Falgunee K Parekh; Vasee S Moorthy
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

8.  Geospatially illustrating regional-based oral health disparities in Kentucky.

Authors:  Daniel M Saman; Andrew O Johnson; Oscar Arevalo; Agricola Odoi
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

Review 9.  Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.

Authors:  Rajeev K Mehlotra; Cara N Henry-Halldin; Peter A Zimmerman
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

Review 10.  Malaria: progress, perils, and prospects for eradication.

Authors:  Brian M Greenwood; David A Fidock; Dennis E Kyle; Stefan H I Kappe; Pedro L Alonso; Frank H Collins; Patrick E Duffy
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.